Comment from Gary Hardy

Summary: Gary L. Hardy opposes the FDA's proposal to remove the 510(k) exemption for devices used in federally regulated drug testing programs. He argues that the current requirement ensures assay accuracy and public safety, and he requests that the FDA provide evidence of safety, define replacement standards, and engage with stakeholders before proceeding.